Drug Profile
Galeterone companion diagnostic
Alternative Names: AR-V7 companion diagnosticLatest Information Update: 07 Jan 2021
Price :
$50
*
At a glance
- Originator Tokai Pharmaceuticals
- Developer Novus Therapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Prostate cancer